Visiongain Insight: The anti-obesity market is entering a sustained growth phase
By introducing new medications and forming collaborations with different caregivers, weve seen real results people feel better and avoid hospitalizations, said Tony Bashall, MD, an Indianapolis cardiologist at Franciscan Health Indiana Heart Physicians with an interest in cardiometabolic health
Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials
10.1021/acs.jafc.5b00377 127
Semaglutide is an FDA-approved medication that has gained attention for its effectiveness in managing weight loss and type 2 diabetes
The treated wounds also had more collagen (a key building block of skin) and more new blood vessels, both signs of better healing